Bayer: Out of Trouble Come Opportunities

Bayer's respiratory diseases spin-out Aerovance shows how new opportunities are springing out of Europe's mid-sized firms, many of which are in transition.

By Melanie Senior

At last, German conglomerate Bayer AG is taking visible steps to save its struggling health care division. Since the...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from In Vivo Archive

More from In Vivo